128 related articles for article (PubMed ID: 32457495)
1. MIR1246 in body fluids as a biomarker for pancreatic cancer.
Ishige F; Hoshino I; Iwatate Y; Chiba S; Arimitsu H; Yanagibashi H; Nagase H; Takayama W
Sci Rep; 2020 May; 10(1):8723. PubMed ID: 32457495
[TBL] [Abstract][Full Text] [Related]
2. miR‑1246 and miR‑4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer.
Machida T; Tomofuji T; Maruyama T; Yoneda T; Ekuni D; Azuma T; Miyai H; Mizuno H; Kato H; Tsutsumi K; Uchida D; Takaki A; Okada H; Morita M
Oncol Rep; 2016 Oct; 36(4):2375-81. PubMed ID: 27573701
[TBL] [Abstract][Full Text] [Related]
3. Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma.
Hoshino I; Ishige F; Iwatate Y; Gunji H; Kuwayama N; Nabeya Y; Yokota H; Takeshita N; Iida K; Nagase H; Matsubara H
PLoS One; 2021; 16(3):e0248016. PubMed ID: 33690683
[TBL] [Abstract][Full Text] [Related]
4. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
[TBL] [Abstract][Full Text] [Related]
5. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P
Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588
[TBL] [Abstract][Full Text] [Related]
6. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.
Zhang L; Farrell JJ; Zhou H; Elashoff D; Akin D; Park NH; Chia D; Wong DT
Gastroenterology; 2010 Mar; 138(3):949-57.e1-7. PubMed ID: 19931263
[TBL] [Abstract][Full Text] [Related]
7. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
[TBL] [Abstract][Full Text] [Related]
8. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
9. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer.
Xie Z; Yin X; Gong B; Nie W; Wu B; Zhang X; Huang J; Zhang P; Zhou Z; Li Z
Cancer Prev Res (Phila); 2015 Feb; 8(2):165-73. PubMed ID: 25538087
[TBL] [Abstract][Full Text] [Related]
10. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
11. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y
PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024
[TBL] [Abstract][Full Text] [Related]
12. 5'‑isomiR is the most abundant sequence of miR‑1246, a candidate biomarker of lung cancer, in serum.
Aiso T; Ueda M
Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36960865
[TBL] [Abstract][Full Text] [Related]
13. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
Jiao Y; Fu Z; Li Y; Zhang W; Liu Y
PLoS One; 2019; 14(1):e0211291. PubMed ID: 30695070
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
15. Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis.
Deng T; Yuan Y; Zhang C; Zhang C; Yao W; Wang C; Liu R; Ba Y
Cell Physiol Biochem; 2016; 39(5):1716-1722. PubMed ID: 27639768
[TBL] [Abstract][Full Text] [Related]
16. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
17. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
[TBL] [Abstract][Full Text] [Related]
18. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
19. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer.
Yang F; Liu DY; Guo JT; Ge N; Zhu P; Liu X; Wang S; Wang GX; Sun SY
World J Gastroenterol; 2017 Dec; 23(47):8345-8354. PubMed ID: 29307994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
